Tolerability of gefitinib in patients receiving treatment in everyday clinical practice

por Zandwijk, N van
Publicado 2003

Docetaxel: an alternative taxane in ovarian cancer

por Katsumata, N
Publicado 2003

The epidemiology of interstitial lung disease and its association with lung cancer

por Raghu, G, Nyberg, F, Morgan, G
Publicado 2004

Understanding the mechanisms of drug-associated interstitial lung disease

por Higenbottam, T, Kuwano, K, Nemery, B, Fujita, Y
Publicado 2004

Prevention of febrile neutropenia: use of prophylactic antibiotics

por Cullen, M, Baijal, S
Publicado 2009

Bladder cancer in cancer patients: population-based estimates from a large Swedish study

por Bermejo, J Lorenzo, Sundquist, J, Hemminki, K
Publicado 2009

Birth intervals and breast cancer risk

por Kauppila, A, Kyyrönen, P, Hinkula, M, Pukkala, E
Publicado 2009

Koilocytes indicate a role for human papilloma virus in breast cancer

por Lawson, J S, Glenn, W K, Heng, B, Ye, Y, Tran, B, Lutze-Mann, L, Whitaker, N J
Publicado 2009

Evaluation of bowel cancer registration data in England, 1996–2004

por Jones, A M, Morris, E, Thomas, J, Forman, D, Melia, J, Moss, S M
Publicado 2009

Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium

por Pearce, C L, Near, A M, Van Den Berg, D J, Ramus, S J, Gentry-Maharaj, A, Menon, U, Gayther, S A, Anderson, A R, Edlund, C K, Wu, A H, Chen, X, Beesley, J, Webb, P M, Holt, S K, Chen, C, Doherty, J A, Rossing, M A, Whittemore, A S, McGuire, V, DiCioccio, R A, Goodman, M T, Lurie, G, Carney, M E, Wilkens, L R, Ness, R B, Moysich, K B, Edwards, R, Jennison, E, Kjaer, S K, Hogdall, E, Hogdall, C K, Goode, E L, Sellers, T A, Vierkant, R A, Cunningham, J M, Schildkraut, J M, Berchuck, A, Moorman, P G, Iversen, E S, Cramer, D W, Terry, K L, Vitonis, A F, Titus-Ernstoff, L, Song, H, Pharoah, P D P, Spurdle, A B, Anton-Culver, H, Ziogas, A, Brewster, W, Galitovskiy, V, Chenevix-Trench, G
Publicado 2009

Brain metastases admissions in Sweden between 1987 and 2006

por Smedby, K E, Brandt, L, Bäcklund, M L, Blomqvist, P
Publicado 2009

Geographical and temporal distribution of cancer survival in teenagers and young adults in England

por Geraci, M, Eden, T O B, Alston, R D, Moran, A, Arora, R S, Birch, J M
Publicado 2009

The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients

por Hamilton, W
Publicado 2009

Awareness of cancer symptoms and anticipated help seeking among ethnic minority groups in England

por Waller, J, Robb, K, Stubbings, S, Ramirez, A, Macleod, U, Austoker, J, Hiom, S, Wardle, J
Publicado 2009

The size of the prize for earlier diagnosis of cancer in England

por Richards, M A
Publicado 2009

Epac inhibits migration and proliferation of human prostate carcinoma cells

por Grandoch, M, Rose, A, ter Braak, M, Jendrossek, V, Rübben, H, Fischer, J W, Schmidt, M, Weber, A A
Publicado 2009

Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth

por Traish, A M, Morgentaler, A
Publicado 2009

Age of onset in familial breast cancer as background data for medical surveillance

por Brandt, A, Bermejo, J Lorenzo, Sundquist, J, Hemminki, K
Publicado 2010

Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses

por Liu, W M, Fowler, D W, Smith, P, Dalgleish, A G
Publicado 2010

Relation of risk of contralateral breast cancer to the interval since the first primary tumour

por Rubino, C, Arriagada, R, Delaloge, S, Lê, M G
Publicado 2010